State Street
NXTC icon

State Street’s NextCure NXTC Stock Holding History

State Street’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,449
Closed -$30.1K – 4346
2025
Q2 		$30.1K Hold
5,449
– – ﹤0.01% 4163
2025
Q1 		$31.4K Hold
5,449
– – ﹤0.01% 4152
2024
Q4 		$50.4K Hold
5,449
– – ﹤0.01% 4105
2024
Q3 		$89.6K Hold
5,449
– – ﹤0.01% 3999
2024
Q2 		$104K Buy
5,449
+691
+15% +$13.4K ﹤0.01% 4004
2024
Q1 		$127K Hold
4,758
– – ﹤0.01% 3981
2023
Q4 		$65.1K Hold
4,758
– – ﹤0.01% 4145
2023
Q3 		$73.6K Hold
4,758
– – ﹤0.01% 4186
2023
Q2 		$103K Hold
4,758
– – ﹤0.01% 4233
2023
Q1 		$84.5K Hold
4,758
– – ﹤0.01% 4373
2022
Q4 		$80.5K Hold
4,758
– – ﹤0.01% 4431
2022
Q3 		$157K Hold
4,758
– – ﹤0.01% 4242
2022
Q2 		$268K Hold
4,758
– – ﹤0.01% 4081
2022
Q1 		$277K Buy
4,758
+460
+11% +$28.8K ﹤0.01% 4270
2021
Q4 		$309K Hold
4,298
– – ﹤0.01% 4177
2021
Q3 		$348K Hold
4,298
– – ﹤0.01% 4120
2021
Q2 		$414K Sell
4,298
-18,559
-81% -$1.9M ﹤0.01% 3931
2021
Q1 		$2.75M Buy
22,857
+429
+2% +$62.1K ﹤0.01% 3307
2020
Q4 		$2.93M Sell
22,428
-1,134
-5% -$147K ﹤0.01% 3202
2020
Q3 		$2.49M Sell
23,562
-69
-0.3% -$8.48K ﹤0.01% 3108
2020
Q2 		$6.08M Sell
23,631
-13,773
-37% -$5.24M ﹤0.01% 2660
2020
Q1 		$16.6M Buy
37,404
+2,690
+8% +$1.44M ﹤0.01% 1958
2019
Q4 		$23.5M Buy
34,714
+30,077
+649% +$15.1M ﹤0.01% 2032
2019
Q3 		$1.72M Buy
4,637
+2,428
+110% +$790K ﹤0.01% 3267
2019
Q2 		$300K Buy
+2,209
New +$459K ﹤0.01% 3571

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CPA
Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street's NXTC Position: Q3 2025 in Review

State Street sold out of NextCure (NXTC) in Q3 2025, closing a stake of 5,449 shares — an estimated $30.1K sold.

State Street first reported a position in NXTC in Q2 2019 and held it in 25 quarters. The position peaked at $23.5M in Q4 2019. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

  • State Street reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
  • State Street sold 5,449 NextCure shares in Q3 2025, an estimated $30.1K.
  • State Street first reported a position in NextCure in Q2 2019 and held it in 25 quarters.
  • State Street's NextCure position peaked at $23.5M in Q4 2019.
  • 17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.